Opportunity Information: Apply for CDC RFA GH16 1682
Apply for CDC RFA GH16 1682
- The HHS-CDC-CGH in the health sector is offering a public funding opportunity titled "Ensuring Adequate Access to HIV/AIDS Screening, Care and Treatment to Key Populations in Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Dec 08, 2015 and posted on Dec 08, 2015.
- Applicants must submit their applications by Feb 08, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,200,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Ensuring Adequate Access to HIV/AIDS Screening, Care and Treatment to Key Populations in Haiti under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a U.S. government-funded initiative administered by the U.S. Centers for Disease Control and Prevention (CDC) under the Department of Health and Human Services (HHS). It is issued as a discretionary cooperative agreement, meaning the awardee would not simply receive funds and operate independently; instead, the recipient would be expected to work closely with CDC with ongoing technical collaboration, shared planning, and performance oversight. The overall intent is to strengthen and expand HIV services in Haiti by building on existing PEPFAR-supported work rather than starting from scratch, with a clear emphasis on improving both access and continuity across the HIV prevention-to-treatment continuum.
The program focus is specifically on "key populations" that carry disproportionate HIV risk and often face major barriers to care. The FOA identifies commercial sex workers (CSW) and their clients, transgender people (TG), and men who have sex with men (MSM) as priority groups. In practical terms, the opportunity targets improved availability and uptake of HIV screening and diagnosis services, stronger linkages to care after a positive test, sustained antiretroviral treatment (ART) engagement, and sexual prevention services tailored to the needs and realities of these groups. Because the named populations frequently experience stigma, discrimination, and safety concerns, the underlying logic of the FOA is that conventional, general-population service delivery models may not be sufficient; the supported activities are expected to improve access in ways that are acceptable, safe, and effective for these communities.
Funding for this opportunity is capped at an award ceiling of $1,200,000, with CDC anticipating a single award. The Funding Opportunity Number is CDC RFA GH16-1682, and it falls under the health funding activity category with CFDA number 93.067, which corresponds to the CDC's global health-related assistance mechanisms. The opportunity was posted on December 8, 2015, created the same day, and had a closing date of February 8, 2016. While the eligibility line is listed broadly as "Others," the announcement indicates that applicants needed to consult the detailed eligibility language in the full FOA for clarification, suggesting the pool could include certain nontraditional entities or specific types of organizations that meet CDC requirements and can operate effectively in Haiti.
At a high level, the grant is meant to support an integrated package of services that typically includes community-appropriate outreach and engagement, HIV testing services, immediate and effective linkage to clinical care for those who test positive, ongoing treatment support to help clients start and stay on ART, and sexual prevention interventions. The reference to "sexual prevention services" signals attention not only to diagnosing and treating HIV but also to reducing onward transmission through prevention counseling and related interventions appropriate to local context and the needs of CSW, TG, and MSM. Taken together, the FOA is framed as a continuation and enhancement of PEPFAR's work in Haiti, aiming to close persistent service gaps for populations that are often underserved despite having high need, and to ensure that screening, care, and treatment are accessible, timely, and sustained.
Frequently Asked Questions (FAQs)
1. What is the title of this grant opportunity?
The opportunity is titled "Ensuring Adequate Access to HIV/AIDS Screening, Care and Treatment to Key Populations in Haiti under the President's Emergency Plan for AIDS Relief (PEPFAR)."
2. Which U.S. government agency is administering this opportunity?
This is a U.S. government-funded initiative administered by the U.S. Centers for Disease Control and Prevention (CDC), under the Department of Health and Human Services (HHS).
3. What type of award is this (grant vs. cooperative agreement)?
This funding is issued as a discretionary cooperative agreement. That means the recipient would be expected to work closely with CDC through ongoing technical collaboration, shared planning, and performance oversight, rather than operating fully independently after receiving funds.
4. What is the main goal of the program?
The overall intent is to strengthen and expand HIV services in Haiti by building on existing PEPFAR-supported work, with a clear emphasis on improving access and continuity across the HIV prevention-to-treatment continuum.
5. What does "building on existing PEPFAR-supported work" mean in practice?
It means the initiative is framed as a continuation and enhancement of ongoing PEPFAR activities in Haiti, aiming to close persistent service gaps and strengthen service delivery rather than starting from scratch with an entirely new approach.
6. Who are the priority populations for this funding?
The program focus is on key populations that face disproportionate HIV risk and barriers to care. The FOA identifies the following priority groups:
- Commercial sex workers (CSW) and their clients
- Transgender people (TG)
- Men who have sex with men (MSM)
7. Why does the FOA emphasize "key populations"?
The FOA highlights that these populations often experience stigma, discrimination, and safety concerns that can limit access to standard, general-population health services. The underlying approach is that conventional service delivery models may not be sufficient, so funded activities are expected to improve access in ways that are acceptable, safe, and effective for these communities.
8. What types of services or activities are expected to be supported?
At a high level, the grant is meant to support an integrated package of services that typically includes:
- Community-appropriate outreach and engagement
- HIV testing services (screening and diagnosis)
- Strong linkages to clinical care after a positive test
- Treatment support to help clients start and stay on antiretroviral treatment (ART)
- Sexual prevention services tailored to the needs and realities of CSW, TG, and MSM
9. What does "continuity across the HIV prevention-to-treatment continuum" refer to?
It refers to ensuring people can move smoothly from prevention and outreach, to HIV testing and diagnosis, to linkage to clinical care, to sustained engagement in treatment (including ART), with fewer drop-offs between steps.
10. Is HIV screening/testing a central part of the program?
Yes. The opportunity specifically targets improved availability and uptake of HIV screening and diagnosis services for key populations in Haiti.
11. What does the FOA say about linkage to care after a positive test?
The program places emphasis on stronger linkages to care after a positive test, meaning people who test positive should be connected to clinical services effectively and without avoidable delays.
12. Does the opportunity address antiretroviral treatment (ART)?
Yes. The FOA emphasizes sustained ART engagement, including ongoing treatment support to help clients start and stay on ART.
13. What are "sexual prevention services" in the context of this FOA?
The FOA signals attention to prevention alongside diagnosis and treatment. It references sexual prevention services that are appropriate to local context and tailored to the needs and realities of CSW, TG, and MSM, with the intent of reducing onward transmission.
14. What is the maximum funding amount available?
The award ceiling for this opportunity is $1,200,000.
15. How many awards does CDC anticipate making?
CDC anticipates a single award.
16. What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is CDC RFA GH16-1682.
17. What is the CFDA number associated with this opportunity?
The opportunity is listed under CFDA number 93.067, which corresponds to CDC global health-related assistance mechanisms.
18. What is the funding activity category?
The opportunity falls under the health funding activity category.
19. When was the opportunity posted, and what were the open and close dates?
The opportunity was posted on December 8, 2015 (and created the same day). The closing date was February 8, 2016.
20. Who was eligible to apply?
The eligibility line is listed broadly as "Others." The announcement indicates applicants needed to consult the detailed eligibility language in the full FOA for clarification, implying eligibility may have been limited to specific types of entities that meet CDC requirements and can operate effectively in Haiti.
21. Does this program focus on Haiti specifically?
Yes. The FOA is specifically aimed at strengthening and expanding HIV services for key populations in Haiti under PEPFAR.
22. How does CDC typically engage with recipients under a cooperative agreement?
Based on the description provided, the recipient should expect ongoing technical collaboration with CDC, shared planning, and performance oversight as part of implementation.
23. What is the broader program context for this opportunity?
This work is framed within the President's Emergency Plan for AIDS Relief (PEPFAR) and is intended to improve access and sustained engagement in HIV screening, care, and treatment services for underserved groups with high need.
Browse more opportunities from the same agency: HHS-CDC-CGH
Browse more opportunities from the same category: Health
Next opportunity: Manufacturing Machines and Equipment
Previous opportunity: Novel Instrumental Techniques for Basic Energy Research: Electrochemistry and Quantum Materials
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH16 1682
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH16 1682) also looked into and applied for these:
| Funding Opportunity |
|---|
| Supporting the National Blood Transfusion Service (NBTS) in the implementation and expansion of Blood Safety activities in the Republic of Zambia under the President’s Emergency plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1709 Funding Number: CDC RFA GH16 1709 Agency: HHS-CDC Category: Health Funding Amount: $1,353,644 |
| Strengthening HIV/AIDS Prevention and Care Services for Highly Vulnerable Populations in the Republic of Côte d’Ivoire Under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10310501SUPP16 Funding Number: CDC RFA PS10 10310501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $3,123,298 |
| National Child Traumatic Stress Initiative, National Center for Child Traumatic Stress Apply for SM 16 003 Funding Number: SM 16 003 Agency: HHS-SAMHS Category: Health Funding Amount: $6,000,000 |
| Service Area Competition – Additional Areas (SAC-AA) – California, District of Columbia, Kansas, Nevada, New York, Oregon, Texas, and Washington Apply for HRSA 16 176 Funding Number: HRSA 16 176 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Service Area Competition – Additional Area (SAC-AA) – Baltimore, Maryland Apply for HRSA 16 177 Funding Number: HRSA 16 177 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| B Cell Immunology Program for HIV-1 Vaccine Development (BCIP) (R01) Apply for RFA AI 15 055 Funding Number: RFA AI 15 055 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Supporting the Provision of High Quality, Comprehensive, and Sustainable HIV Services in National Teaching and Referral Hospitals in the Republic of Kenya under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1621 Funding Number: CDC RFA GH16 1621 Agency: HHS-CDC-CGH Category: Health Funding Amount: $10,500,000 |
| Research to Advance Primary Care-Pharmacy Linkage for Medication Review to Reduce Older Adult Falls Apply for RFA CE 16 002 Funding Number: RFA CE 16 002 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $350,000 |
| Increase Access to Care for Black Men Who Have Sex with Men Apply for RFA PS 16 004 Funding Number: RFA PS 16 004 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $400,000 |
| Oral Health Service Expansion Apply for HRSA 16 076 Funding Number: HRSA 16 076 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| NHLBI Outstanding Investigator Award (OIA) (R35) Apply for RFA HL 16 024 Funding Number: RFA HL 16 024 Agency: HHS-NIH11 Category: Health Funding Amount: $500,000 |
| Scaling Integrated, Effective and Sustainable Services for the Prevention of Mother to Child HIV Transmission (PMTCT) in the Republic of Uganda under PEPFAR Apply for CDC RFA PS10 10210501SUPP16 Funding Number: CDC RFA PS10 10210501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $2,458,270 |
| Provision of comprehensive, community-based HIV/AIDS Services and Capacity Building of Indigenous Organizations in the Republic of Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10180501SUPP16 Funding Number: CDC RFA PS10 10180501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $965,884 |
| Novel Genomic Technology Development (R21) Apply for PAR 16 015 Funding Number: PAR 16 015 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Ryan White HIV/AIDS Program Part D Grants for Coordinated HIV Services and Access to Research for Women, Infants, Children, and Youth (WICY) Supplemental Apply for HRSA 16 087 Funding Number: HRSA 16 087 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| AIDS Education and Training Center National Clinician Consultation Center Apply for HRSA 16 173 Funding Number: HRSA 16 173 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Global Noncommunicable Disease Prevention and Promotion of Health Apply for CDC RFA GH14 142003CONT16 Funding Number: CDC RFA GH14 142003CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement to Support the Establishment of a Southeast Asia Regional HIV Addiction Technology Transfer Center (ATTC) (Short Title: SE Asia Regional HIV ATTC) Apply for TI 16 004 Funding Number: TI 16 004 Agency: HHS-SAMHS Category: Health Funding Amount: $250,000 |
| Strengthening HIV Clinical Services within a Network of Public and Private Health Institutions in the West, South, and North West Departments of Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1711 Funding Number: CDC RFA GH16 1711 Agency: HHS-CDC-CGH Category: Health Funding Amount: $6,000,000 |
| National Stop Transmission of Polio (NSTOP) initiative supporting polio eradication in Africa Apply for CDC RFA GH15 161202CONT16 Funding Number: CDC RFA GH15 161202CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH16 1682", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.